Lord Abbett Micro Cap Growth Fund Class I (LMIYX)
| Fund Assets | 186.37M |
| Expense Ratio | 1.13% |
| Min. Investment | $1,000,000 |
| Turnover | 122.00% |
| Dividend (ttm) | 0.00 |
| Dividend Yield | 0.01% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 2, 2025 |
| Previous Close | 24.30 |
| YTD Return | 1.41% |
| 1-Year Return | 14.10% |
| 5-Year Return | -13.77% |
| 52-Week Low | 16.02 |
| 52-Week High | 26.02 |
| Beta (5Y) | 1.13 |
| Holdings | 73 |
| Inception Date | Jul 9, 1999 |
About LMIYX
The Lord Abbett Micro Cap Growth Fund Class I is an institutional mutual fund focused on achieving long-term capital appreciation by investing primarily in equity securities of micro-cap companies in the United States. Micro-cap companies are defined as firms with market capitalizations typically below $1 billion or within the range represented in the Russell Microcap® Index. The fund uses a fundamental research-driven approach, seeking out companies that demonstrate faster-than-average earnings growth and strong profit potential. Its portfolio is diverse, spanning sectors such as healthcare, technology, industrials, and consumer discretionary, with holdings regularly updated to reflect market opportunities and management insight. This fund is designed for institutional investors, featuring a minimum initial investment of $1,000,000 and an expense ratio of approximately 1.13%. It maintains a portfolio of around 70 to 75 holdings, with an active management style resulting in a relatively high turnover rate. The fund may also allocate up to 10% of assets to international companies, including those in emerging markets. With an inception dating back to 1999, Lord Abbett Micro Cap Growth Fund Class I has established a notable presence in the small growth mutual fund category, serving as a vehicle for investors seeking exposure to the dynamic and high-potential segment of micro-cap equities.
Performance
LMIYX had a total return of 14.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 23.57%.
Top 10 Holdings
29.03% of assets| Name | Symbol | Weight |
|---|---|---|
| Cogent Biosciences, Inc. | COGT | 4.45% |
| Tarsus Pharmaceuticals, Inc. | TARS | 3.40% |
| Adaptive Biotechnologies Corporation | ADPT | 3.40% |
| Argan, Inc. | AGX | 3.28% |
| GeneDx Holdings Corp. | WGS | 2.76% |
| Celcuity Inc. | CELC | 2.64% |
| TeraWulf Inc. | WULF | 2.43% |
| Artivion, Inc. | AORT | 2.31% |
| Applied Digital Corporation | APLD | 2.23% |
| Willdan Group, Inc. | WLDN | 2.13% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 2, 2025 | $0.0019 | Dec 2, 2025 |
| Nov 24, 2020 | $5.0784 | Nov 24, 2020 |
| Nov 21, 2019 | $2.3699 | Nov 21, 2019 |
| Nov 20, 2018 | $4.9908 | Nov 20, 2018 |
| Nov 21, 2017 | $2.701 | Nov 21, 2017 |
| Nov 24, 2015 | $3.1958 | Nov 24, 2015 |